Home / Crime and Justice / J&J Talc Cancer Verdict: $65.5M Awarded
J&J Talc Cancer Verdict: $65.5M Awarded
20 Dec, 2025
Summary
- A jury awarded $65.5 million to a mother with lung cancer.
- She claimed talcum products caused her illness.
- Johnson & Johnson plans to appeal the verdict.

A Minnesota jury recently delivered a $65.5 million verdict in favor of a mother of three who alleged that Johnson & Johnson's talcum products led to her developing lung cancer. The plaintiff, Anna Jean Houghton Carley, 37, claimed prolonged use of the company's baby powder, including throughout her childhood, contributed to her mesothelioma, an aggressive cancer. Her legal team argued that Johnson & Johnson knew about the potential for asbestos contamination in its talc-based products but continued to market them without adequate warnings.
During a 13-day trial, Carley's attorneys presented evidence suggesting the pharmaceutical giant failed to inform consumers about the risks associated with their talc products. Johnson & Johnson, however, has maintained its baby powder is safe and free from asbestos, vowing to appeal the jury's decision. The company's worldwide vice president of litigation expressed confidence that an appellate court would overturn the verdict, dismissing the lawsuits as based on "junk science."




